These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3729611)
1. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction. Kron IL; Lerman B; DiMarco JP Ann Thorac Surg; 1986 Jul; 42(1):13-6. PubMed ID: 3729611 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias. Garan H; Ruskin JN; DiMarco JP; Derkac WM; Akins CW; Daggett WM; Austen WG; Buckley MJ Am J Cardiol; 1983 Feb; 51(3):519-24. PubMed ID: 6600577 [TBL] [Abstract][Full Text] [Related]
3. Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction. Bhandari AK; Au PK; Rose JS; Kotlewski A; Blue S; Rahimtoola SH Am J Cardiol; 1987 Feb; 59(4):284-90. PubMed ID: 3812277 [TBL] [Abstract][Full Text] [Related]
4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
5. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction. Rodriguez LM; Smeets J; O'Hara GE; Geelen P; Brugada P; Wellens HJ Am J Cardiol; 1992 Jun; 69(17):1403-6. PubMed ID: 1590227 [TBL] [Abstract][Full Text] [Related]
6. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290 [TBL] [Abstract][Full Text] [Related]
7. Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Misier AR; Opthof T; van Hemel NM; Vermeulen JT; de Bakker JM; Defauw JJ; van Capelle FJ; Janse MJ Circulation; 1995 May; 91(10):2566-72. PubMed ID: 7743618 [TBL] [Abstract][Full Text] [Related]
8. Surgical management of refractory ventricular arrhythmias in patients with prior inferior myocardial infarction. A preliminary report. Ivey TD; Brady GH; Misbach GA; Greene HL J Thorac Cardiovasc Surg; 1985 Mar; 89(3):369-77. PubMed ID: 3974272 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic characteristics of ventricular tachycardia or fibrillation in relation to age of myocardial infarction. Stevenson WG; Brugada P; Kersschot I; Waldecker B; Zehender M; Geibel A; Wellens HJ Am J Cardiol; 1986 Feb; 57(6):387-91. PubMed ID: 3946252 [TBL] [Abstract][Full Text] [Related]
10. Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction. Rodriguez LM; Oyarzun R; Smeets J; Brachmann J; Schmitt C; Brugada P; Geelen P; Lipcsei G; Albert A; Wellens HJ Am J Cardiol; 1992 Feb; 69(5):462-4. PubMed ID: 1736607 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone. Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883 [TBL] [Abstract][Full Text] [Related]
12. Results of electrophysiologically guided operations for drug-resistant recurrent ventricular tachycardia and ventricular fibrillation due to coronary artery disease. Brodman R; Fisher JD; Johnston DR; Kim SG; Matos JA; Waspe LE; Scavin GM; Furman S J Thorac Cardiovasc Surg; 1984 Mar; 87(3):431-8. PubMed ID: 6700249 [TBL] [Abstract][Full Text] [Related]
13. Argon laser ablation of malignant ventricular tachycardia associated with coronary artery disease. Saksena S; Gielchinsky I; Tullo NG Am J Cardiol; 1989 Dec; 64(19):1298-304. PubMed ID: 2589195 [TBL] [Abstract][Full Text] [Related]
14. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Bourke JP; Richards DA; Ross DL; McGuire MA; Uther JB Am J Cardiol; 1995 Mar; 75(7):431-5. PubMed ID: 7863984 [TBL] [Abstract][Full Text] [Related]
16. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. Hohnloser SH; Raeder EA; Podrid PJ; Graboys TB; Lown B Am Heart J; 1987 Jul; 114(1 Pt 1):1-7. PubMed ID: 3604854 [TBL] [Abstract][Full Text] [Related]
17. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence. Heidbüchel H; Tack J; Vanneste L; Ballet A; Ector H; Van de Werf F Circulation; 1994 Mar; 89(3):1051-9. PubMed ID: 8124790 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811 [TBL] [Abstract][Full Text] [Related]